Cargando…
Prospective Evaluation of Universal BRCA Testing for Women With Triple-Negative Breast Cancer
BACKGROUND: Limited published literature exists on women with triple-negative breast cancer (TNBC) diagnosed over the age of 60 years with breast cancer gene (BRCA) pathogenic variants. Our study determined whether the rate of BRCA pathogenic variants in a prospective cohort of TNBC patients outside...
Autores principales: | Emborgo, Trisha S, Saporito, Donika, Muse, Kimberly I, Barrera, Angelica M Gutierrez, Litton, Jennifer K, Lu, Karen H, Arun, Banu K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083268/ https://www.ncbi.nlm.nih.gov/pubmed/32211581 http://dx.doi.org/10.1093/jncics/pkaa002 |
Ejemplares similares
-
Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic Testing
por: Elsayegh, Nisreen, et al.
Publicado: (2016) -
Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative
por: Elsayegh, Nisreen, et al.
Publicado: (2015) -
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells
por: Arun, Banu, et al.
Publicado: (2015) -
Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences
por: Makhnoon, Sukh, et al.
Publicado: (2022) -
Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer
por: Garber, Haven R., et al.
Publicado: (2022)